Dual Diagnosis
Dual diagnosis — also called co-occurring disorders or comorbid substance use and mental illness — refers to the co-occurrence of a substance use disorder and one or more other mental-health conditions. It is the rule rather than the exception in clinical SUD populations.
Overview
Dual diagnosis (also called co-occurring disorders, COD, or comorbid mental illness and substance use disorder) refers to the simultaneous presence of a substance use disorder (SUD) and one or more other mental-health conditions in the same individual. The term is widely used in clinical practice though it is not a discrete DSM-5-TR diagnosis. It encompasses any combination of substance use disorder with mood disorders, anxiety disorders, PTSD, ADHD, personality disorders, psychotic disorders, eating disorders, or other conditions.
Dual diagnosis is extraordinarily common. Approximately 50-60% of individuals with substance use disorders have at least one co-occurring mental-health condition; conversely, individuals with serious mental illness have substantially elevated rates of substance use disorders compared to general population (often 2-4x). Specific high-comorbidity combinations include alcohol use disorder + depression, opioid use disorder + PTSD, stimulant use disorder + ADHD, and any SUD + bipolar disorder.
Dual diagnosis is associated with worse outcomes than either condition alone: more severe symptoms, more relapses, more hospitalizations, higher suicide risk, more legal involvement, more housing instability, and shorter life expectancy. The conditions interact bidirectionally — substance use can precipitate, mimic, or worsen mental illness; mental illness can drive self-medication with substances.
Historically, mental-health and addiction services were segregated — patients were told to “get sober first” before mental-health treatment, or to “get mental-health stable first” before addiction treatment. Substantial evidence now supports integrated treatment, in which both conditions are addressed simultaneously by the same team. Integrated dual-diagnosis treatment produces better outcomes than sequential or parallel care across multiple outcome measures.
Effective treatment requires accurate assessment of both conditions, integrated care planning, attention to medication interactions, trauma-informed practice, peer support that addresses both conditions, and sustained engagement. Recovery is possible and is the typical outcome with appropriate care.
Signs and symptoms
- Substance use disorder symptoms — Loss of control, craving, tolerance, withdrawal, continued use despite consequences — meeting DSM-5-TR criteria for SUD.
- Mental-health condition symptoms — Concurrent symptoms of depression, anxiety, PTSD, mania, psychosis, ADHD, personality disorder, or other mental-health condition meeting diagnostic criteria.
- Symptoms that overlap or interact — Difficulty distinguishing substance-induced from primary symptoms; symptoms that worsen during use, withdrawal, or both.
- Use to manage mental-health symptoms — Pattern of using substances to manage mood, anxiety, sleep, trauma symptoms, or other distress — common across SUD populations.
- Worsening course over time — Progressive worsening of both conditions; treatment of one without the other producing only partial improvement.
- Treatment failures with single-focus care — History of multiple unsuccessful treatment attempts when only one condition was addressed at a time.
- Functional impairment — Significant impairment in work, school, relationships, finances, housing, or self-care attributable to the combined conditions.
- Suicide risk — Substantially elevated suicide risk compared to either condition alone; particularly elevated during acute periods of either condition.
- Medical complications — Higher rates of medical comorbidity (cardiovascular disease, infectious disease, liver disease, traumatic brain injury) due to combined effects.
- Social and legal consequences — Higher rates of homelessness, incarceration, family disruption, and unemployment compared to either condition alone.
Diagnostic context
Dual diagnosis is not a single DSM-5-TR diagnostic code — it is the contemporaneous presence of two or more diagnoses. Accurate assessment requires:
- Comprehensive psychiatric and substance-use history including age of onset of each condition.
- Determination of whether mental-health symptoms predate, post-date, or co-occur with substance use onset.
- Assessment of symptoms during periods of abstinence (when possible) to distinguish substance-induced from primary symptoms.
- Validated screening instruments for both substance use (AUDIT, DAST, ASSIST) and mental-health conditions (PHQ-9, GAD-7, PCL-5, MDQ, ASRS).
- Toxicology testing where appropriate.
- Medical evaluation for substance-related and primary medical conditions.
- Family and collateral information when available.
The DSM-5-TR provides framework for distinguishing primary mental disorders from substance/medication-induced disorders. Substance-induced disorders meet diagnostic criteria for the relevant condition but develop during or shortly after substance intoxication or withdrawal and resolve within a defined period after discontinuation. Primary mental disorders persist beyond substance effects and predate or post-date substance use independently.
Common dual diagnoses encountered:
- Alcohol Use Disorder + Major Depressive Disorder
- Alcohol Use Disorder + Generalized Anxiety Disorder or Social Anxiety Disorder
- Opioid Use Disorder + PTSD
- Cannabis Use Disorder + Depression or Anxiety
- Stimulant Use Disorder + ADHD
- Any SUD + Bipolar Disorder
- Any SUD + Borderline or other Cluster B Personality Disorder
- SUD + Schizophrenia or other psychotic disorder
- SUD + Eating Disorder
Causes and risk factors
The high comorbidity between substance use and mental health conditions reflects multiple interacting mechanisms:
Shared genetic vulnerability: substance use disorders and many mental-health conditions share genetic risk factors. General “p-factor” psychiatric vulnerability and specific shared vulnerabilities (e.g., between SUD and depression, ADHD, schizophrenia) are documented.
Shared neurobiological substrates: dopaminergic, serotonergic, and glutamatergic dysregulation; HPA-axis abnormalities; prefrontal-limbic regulation difficulties — all are shared across SUDs and many mental-health conditions.
Self-medication: mental-health symptoms often drive substance use as a coping strategy. Alcohol for anxiety, opioids for trauma symptoms, stimulants for ADHD or depression, cannabis for sleep, all are common patterns.
Substance-induced effects: chronic substance use can precipitate, mimic, or worsen mental-health conditions. Alcohol-induced depression, cannabis-induced psychosis, and stimulant-induced mood and anxiety symptoms are well-documented.
Common environmental risk factors: childhood adversity, trauma exposure, poverty, discrimination, social isolation, and chronic stress all elevate risk for both substance use and mental-health conditions.
Bidirectional worsening: once both conditions are present, each tends to worsen the other. Substance use disrupts treatment adherence for mental-health conditions; mental-health symptoms drive ongoing substance use; medications interact.
Treatment system fragmentation: historical separation of mental-health and addictions services has contributed to under-recognition and under-treatment of dual diagnosis. Many systems still struggle with integrated care delivery.
Typical treatments
The current standard of care is integrated treatment — both conditions addressed simultaneously by the same team or in coordinated programs. Key principles:
Integrated assessment: comprehensive evaluation of both conditions at intake, with ongoing reassessment.
Stage-matched intervention: matching intervention intensity to engagement stage (engagement, persuasion, active treatment, relapse prevention) and to severity. Motivational approaches are key in early stages.
Medications for both conditions when appropriate: antidepressants, mood stabilizers, antipsychotics, and other psychiatric medications are appropriate alongside MAT. Specific medication-substance interactions are monitored. SSRIs are generally safe in most SUDs; benzodiazepines are typically avoided except in specific contexts due to dependence and interaction risks.
Psychotherapy targeting both: evidence-based modalities adapted for dual diagnosis include integrated CBT, Seeking Safety (PTSD + SUD), DBT (BPD + SUD), and others. Trauma-focused work is important given high trauma comorbidity.
Peer support that addresses both: Double Trouble in Recovery, dual-recovery support groups, and traditional 12-step programs that accept psychiatric medication use.
Recovery support services: housing, employment, peer recovery coaches, family education and support.
Coordinated specialty care: for first-episode psychosis with substance use, coordinated specialty care models (early intervention with integrated psychiatric, substance use, and psychosocial care) produce best outcomes.
Harm reduction integration: harm-reduction approaches (naloxone, supervised consumption, drug-checking) are appropriate for individuals not engaging in abstinence-oriented treatment, regardless of mental-health status.
Family involvement: family members are often substantially affected; family education, support, and (when appropriate) family therapy are integral to comprehensive care.
Long-term, recovery-oriented framework: dual diagnosis recovery is typically multi-year. Sustained engagement, gradual stabilization, and progress in multiple life domains are realistic expectations.
When to seek help
Professional support is indicated when:
- You have a diagnosed mental-health condition and are using substances in ways that affect your recovery, medication, or symptom management.
- You have a substance use disorder and are experiencing symptoms of depression, anxiety, PTSD, mania, psychosis, or other mental-health concerns.
- Treatment for either condition alone has not produced sustained improvement.
- You have been told by clinicians that you “need to get sober first” or “get psychiatrically stable first” — integrated approaches that address both simultaneously typically produce better outcomes.
- You are using substances to manage symptoms of a mental-health condition.
- Suicide risk, self-harm urges, or thoughts of harming others are present.
- You are having difficulty accessing or coordinating care across multiple systems.
Free 24-hour crisis and addictions support: 9-8-8 (Suicide Crisis Helpline), 1-833-456-4566 (Talk Suicide Canada), 1-866-332-2322 (Alberta Health Services Addiction Helpline, 24/7), 1-866-531-2600 (ConnexOntario, 24/7), 1-855-242-3310 (Hope for Wellness Helpline, Indigenous-led, 24/7).
Frequently asked questions
Is dual diagnosis a separate diagnosis?
Should I treat the addiction first or the mental illness first?
Can I take psychiatric medication if I am in recovery from substance use?
Is one condition causing the other?
How long does dual-diagnosis treatment take?
My family member has both an addiction and mental illness — what can I do?
References
- Substance Abuse and Mental Health Services Administration. (2020). Substance Use Disorder Treatment for People With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42.
- Drake, R. E., et al. (2008). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 31(4), 360–374.
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
- Mueser, K. T., Noordsy, D. L., Drake, R. E., & Fox, L. (2003). Integrated Treatment for Dual Disorders: A Guide to Effective Practice. Guilford Press.
- Najavits, L. M. (2002). Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. Guilford Press.
Find the pattern behind what's been feeling hard
A few simple questions to help surface the concerns that may fit best.
Find Your PatternFind a Therapist by City
Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.
